We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Other uncategorised cookies are those that are being analysed and have not been classified into a category as yet.
Dermatitis and eczema are manifestations of chronic barrier dysfunction, immune dysregulation, and microbial imbalance. Whether atopic, contact, or irritant in nature, these conditions share a common pathophysiological profile: compromised epidermal integrity, heightened Th2/Th17-driven inflammation, and reduced microbial diversity—factors that impair resilience, promote recurrent flares, and lead to structural degradation of the skin over time.
AWvi addresses dermatitis and eczema not through symptomatic suppression, but by restoring biological function across barrier, immune, and microbial axes. Each solution targets a distinct contributor to cutaneous dysregulation—internally and externally. This integrative approach supports remission stability, reduces flare intensity, and promotes recovery through physiological recalibration.
CORE ESSENTIAL – Fundamental to restore or maintain physiological skin function
The Skin Biotic targets systemic immune imbalance and dysbiosis via modulation of the gut–skin axis. With three proprietary Lactobacillus strains, prebiotics, and bioavailable Retinol and D-Biotin, it provides foundational support for epithelial integrity, immune tolerance, and microbial regulation.
Its primary actions include:
The Skin Biotic acts upstream of flare formation, supporting long-term immune stability and epidermal regeneration from within.
CORE ESSENTIAL – Fundamental to restore or maintain physiological skin function
The Gentle Cleanser is formulated for skin vulnerable to barrier damage and microbial imbalance. Its surfactant-free system, enriched with ectoin, biomimetic hyaluronic acid, and active waters, enables effective cleansing without triggering inflammatory responses.
Key benefits include:
In eczema and dermatitis-prone skin, daily cleansing must preserve—not challenge—physiological defences. This formulation fulfils that role.
CORE ESSENTIAL – Fundamental to restore or maintain physiological skin function
The Active Cream offers lipid replenishment, barrier repair, and immune modulation—essential elements in the ongoing management of eczema and dermatitis. It contains biomimetic triglycerides, broad-spectrum hyaluronic acid, and ectoin.
Key mechanisms include:
The Active Cream is particularly suited for both maintenance and post-flare care, supporting long-term skin stability in reactive phenotypes.




